Healius (ASX:HLS) entered a binding agreement to sell its Lumus Imaging subsidiary to funds managed by Affinity Equity Partners in a deal that values the business at AU$965 million, according to a Monday filing with the Australian bourse.
The sale is expected to reap AU$835 million in proceeds after repayment of equipment leases and more than AU$800 million after transaction fees, separation costs, and other fees, the filing stated.
The deal is expected to close in Q1 2025, subject to Foreign Investment Review Board approval, according to the filing.